Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 1815368 in the Blood
Sponsor: Boehringer Ingelheim
Summary
The main objective of this trial is to investigate the effect on the exposure of BI 1815368 in plasma when given as oral single dose together with multiple oral doses of itraconazole (Test, T) as compared to when given alone as oral single dose (Reference, R).
Official title: Effect of Itraconazole on the Pharmacokinetics of a Single Oral Dose of BI 1815368 in Healthy Male Subjects (an Open-label, Two-period Fixed-sequence Design Study)
Key Details
Gender
MALE
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
14
Start Date
2023-08-02
Completion Date
2023-10-24
Last Updated
2026-05-12
Healthy Volunteers
Yes
Conditions
Interventions
BI 1815368
BI 1815368
Itraconazole
Itraconazole
Locations (1)
Humanpharmakologisches Zentrum Biberach
Biberach, Germany